Navigation Links
NIAID researchers show how promising TB drug works

called FGD1 and F420, neither of which interacts directly with the drug.

Next, the investigators screened for PA-824-resistant M. tb that retained sensitivity to a close relative of PA-824. Within this subgroup of PA-824-resistant bacteria, the team identified those mutant strains with FGD1 and F420. The investigators reasoned that resistance to PA-824 in mutants possessing FGD1 and F420 must be due to a mutation in the M. tb protein that directly interacts with PA-824.

But determining exactly which of M. tb's thousands of proteins was changed in these mutants proved difficult, says Dr. Barry. Conventional genetic techniques for comparing normal and mutant strains of M. tb failed, so the team turned to a specially modified microarray-based technique, called comparative genome sequencing, developed by NimbleGen Systems, Inc. (Madison, WI). This was the first time the technique has been used to identify a protein involved in TB drug resistance, notes Dr. Barry.

Using the NimbleGen technique, which effectively re-sequences the entire genome of the bacterium, the scientists quickly pinpointed the protein altered in the PA-824-resistant mutant strains of M. tb. In the past, such a complete genome comparison might have taken many months of work; this new technology enables scientists to zero in on the specific genetic difference between mutant and normal bacterial strains in just days, says Dr. Barry.

The scientists found a total of four PA-824-resistant mutant strains: two lacked the newly described M. tb protein altogether, while the remaining two mutants evidently acquired resistance to PA-824 through a mutation that made the protein unable to bind to the drug, Dr. Barry says.

With the discovery of the specific protein that interacts with PA-824, Dr. Barry and colleagues, including researchers at the Novartis Institute for Tropical Diseases in Singapore, have information they can use to produce improved PA-824 relatives and accel
'"/>

Source:NIH/National Institute of Allergy and Infectious Diseases


Page: 1 2 3

Related biology news :

1. NIAID Initiates Trial of Experimental Avian Flu Vaccine
2. NIAID begins clinical trial of West Nile virus vaccine
3. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
4. NIAID DNA vaccine for H5N1 avian influenza enters human trial
5. NIAID expands capability for influenza research and surveillance
6. NYU researchers simulate molecular biological clock
7. Vital step in cellular migration described by UCSD medical researchers
8. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
9. UCSD researchers maintain stem cells without contaminated animal feeder layers
10. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
11. New protein discovered by Hebrew University researchers

Post Your Comments:
(Date:12/1/2009)...UMBUS, Ohio Ohio State University cancer research...oth kills brain-tumor cells and blocks the growth ...ws that viruses designed to kill cancer cells onc...gressive brain tumors if they also carry a gene fo...The protein, called vasculostatin, is normally pro...
(Date:12/1/2009)... , NEW YORK, Dec. 1 iQor, a ...PO) services, was included in the 2009 InfoWorld ...metric-enabled ERP system, TeQ21. This was the fir...e recognized among this prestigious list of compan.... "TeQ21 is completely transforming the way we do ...
(Date:12/1/2009)...eliness, like a bad cold, can spread among groups ...the University of California-San Diego and Harvard...ale study that has been following health condition... that lonely people tend to share their loneliness...ly, disconnected people moves to the fringes of so...
Breaking Biology News(10 mins):Tumor-attacking virus strikes with 'one-two punch' 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Loneliness can be contagious 2Loneliness can be contagious 3Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 1Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 2Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 3TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 1TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 2TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 3TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 4More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 1More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 2More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 3More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 4
...he projects will together provide to the GBIF netw...8 million species-occurrence data records as well ...rencing service and a workflow for extracting info...vailable in a database format). , As directed in t... address major global issues, including Global Cli...
...il 2008 - FEBS Letters, one of the leading journal...unced today an exciting new enhancement to the jou... , A Structured Digital Abstract in FEBS Letters ...tract comprising of a series of sentences each of ...al entities, mentioning the method used to study t...
... Care Congress is the premier forum for health car...s and to network with key leaders. The 2008 Congre...fficials from the nation,s largest employers, hosp...l and biotech companies, and government. , One of...alth Care Agenda, will feature key health care adv...
Other Biology News:GBIF seed money awards for 2007-2008 2FEBS Letters Structured Digital Abstracts experiment 25th Annual World Health Care Congress April 21-23, Washington, D.C. 2
(Date:12/1/2009)... Reportlinker.com announces that a ...alogue: ,, Industrial Enzymes - A Global Marke...431/Industrial-Enzymes---A-Global-Market-Report.ht...y with few strong players and a host of small supp...petition and commoditization characterize the indu...
(Date:12/1/2009)...PRNewswire-Asia/ -- Shanghai ChemPartner, as the,f...-based Contract Research,Organization (CRO), today...hnology Fast 50 China, ranking 3rd on the list of ...The award is a testament to ChemPartner,s outstand...,, The results of the 2009 Deloitte Technol...
(Date:12/1/2009)...nc. today announced a collaborative research agree... at evaluating EpiVax’s proprietary Tregitop...mental immune responses to certain drugs. In the c...x Tregitope technology will be evaluated for its e...ics. , (Vocus) December 2...
(Date:12/1/2009)... VANCOUVER, British Columbia, Dec. 1 /PRNewswire-F...subsidiary of The Dow Chemical Company (NYSE: DO...d the signing of a research and commercial license...Sciences with access to Agrisoma,s proprietary Eng...e basis in major food crops, and on a non-exclusiv...
Breaking Biology Technology:Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3
...1 Cardium Therapeutics (Amex:,CXM) announced that...ct,offering with institutional and other accredite...nced on January 31, 2008. Empire Asset Management,...transaction., (Logo: http://www.newscom.com/cgi-...ere offered pursuant to an effective shelf registr...
...Feb. 1 Amicus Therapeutics,Inc. (Nasdaq: FOLD ),...nd,Chief Executive Officer, will present a corpora...al, Biotechnology & Medical Device Conference in,N... am (Eastern Standard,Time) at the Grand Hyatt Hot...y be accessed by visiting,Amicus, website at http...
...IFF LAKE, N.J., Feb. 1 Eisai Co., Ltd.,(Headquart...i,s U.S.,subsidiary, Eisai Corporation of North Am... Chairman & CEO: Hajime Shimizu), today announced .... Food and Drug,Administration (FDA) of a New Drug...in mesylate) for third-line treatment of advanced ...
Other Biology Technology:Cardium Completes $5.3 Million Registered Direct Offering 2Cardium Completes $5.3 Million Registered Direct Offering 3Cardium Completes $5.3 Million Registered Direct Offering 4Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 2Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 3Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application 2Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application 3
Cyno Serum from Innovative Research
Normal Porcine Serum from Equitech-Bio
Porcine Serum from Irvine Scientific
Anti-Foam Reagent from Promega
Biology Products: